44th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID 2026)
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 44th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID 2026) — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
Annual Meeting of the European Society of Paediatric Infectious Diseases (ESPID) 2026
Event type: Medical conference, paediatric infectious diseases, clinical research, diagnostics, vaccines, public health, hospital education, laboratory science
Estimated attendance: Typically a strong specialist medical audience, with expected footfall likely in the range of 1,500 to 2,500+ attendees depending on final program, host city, and partner participation. This event is generally high-value rather than high-volume, meaning the attendee list is more important for quality than sheer size.
Overview
The Annual Meeting of the European Society of Paediatric Infectious Diseases is a highly specialized international medical event focused on infections in infants, children, and adolescents. It brings together clinical experts, hospital leaders, researchers, diagnostic specialists, pharmaceutical stakeholders, vaccine teams, public health professionals, and academic institutions working in paediatric infectious diseases and related disciplines.
This is not a broad consumer health expo. It is a precision-targeted scientific and medical meeting where the best buyer value sits with decision-makers in hospitals, universities, laboratories, biotech companies, pharmaceutical firms, and public health organizations. For attendee-list research, this event is especially useful when the client serves healthcare, diagnostics, research tools, vaccines, laboratory equipment, medical software, or specialist education markets.
1️⃣ Who attends: Buyers / attendees
The audience is mainly made up of medical professionals and healthcare decision-makers with direct relevance to paediatric infectious disease prevention, diagnosis, treatment, research, and policy. Because the event is scientific and specialist-led, the buyer side is often composed of people who influence purchasing rather than retail-style end users.
Main attendee groups include:
- Paediatric infectious disease consultants and specialists
- Hospital clinicians, senior registrars, fellows, and medical educators
- Microbiologists, virologists, immunologists, and laboratory directors
- Researchers from universities, children’s hospitals, and medical institutes
- Pharmaceutical medical affairs and clinical development teams
- Vaccine researchers and immunization program specialists
- Public health and epidemiology professionals
- Diagnostics and pathology decision-makers
- Medical device and laboratory equipment companies
- Scientific publishers, education providers, and congress sponsors
In buyer terms, the strongest contacts are usually directors, consultants, heads of department, principal investigators, medical affairs leaders, procurement influencers in hospitals, and technical specialists involved in product selection and clinical adoption.
2️⃣ Where the show is happening + attendee geographic origin
The exact 2026 host city and venue should be confirmed from the official meeting page before the final list build. This event rotates across major European conference destinations, and the location can influence which countries are most represented.
Geographic origin: Primarily Europe, but with a meaningful international presence from the United Kingdom, North America, the Middle East, Asia-Pacific, and global healthcare organizations. The event is European in identity but international in attendee mix, especially among researchers, industry sponsors, and scientific collaborators.
Best geographic targeting:
- European Union and EEA countries
- United Kingdom and Ireland
- Switzerland and other major research hubs
- International pharma and biotech headquarters in Europe
- Global medical device and diagnostics companies
- Hospital networks and academic institutions with paediatric research programs
3️⃣ Audience reach
Reach type: Regional with international/global influence
The core audience is European, but the scientific relevance makes it globally attractive. The event has a strong international reputation among paediatric infectious disease professionals, which means it can generate interest from multinational companies, research sponsors, vaccine developers, and diagnostic manufacturers operating across multiple markets.
4️⃣ Sample buyer company names + websites
Below is a sample buyer table with organizations that would be relevant for attendee-list targeting. These are not random names; they represent likely buyers, sponsors, exhibitors, research partners, or organizations with active interest in paediatric infectious disease, vaccines, diagnostics, antimicrobial stewardship, hospital care, or clinical education.
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Pfizer | pfizer.com | Medical Affairs Director / Vaccines Brand Lead / Clinical Development Manager | Strong vaccine and infectious disease presence; highly relevant to paediatric prevention and immunization discussions. |
| 2 | GSK | gsk.com | Medical Science Liaison / Vaccine Medical Lead / Global Brand Manager | Major vaccine and infectious disease stakeholder with strong conference buying interest. |
| 3 | Sanofi | sanofi.com | Medical Affairs Manager / Vaccines Strategy Lead / Clinical Research Director | Relevant across vaccines, paediatrics, immunology, and infectious disease partnerships. |
| 4 | MSD (Merck) | msd.com | Clinical Development Lead / Medical Affairs Director / Market Access Manager | Pharma buyer fit for anti-infectives, vaccines, and hospital-focused therapies. |
| 5 | Roche | roche.com | Diagnostics Product Manager / Medical Affairs Lead / Hospital Account Director | Very strong fit for infectious disease diagnostics, lab solutions, and clinical research engagement. |
| 6 | Abbott | abbott.com | Diagnostics Marketing Manager / Clinical Specialist / Hospital Sales Manager | Relevant for rapid diagnostics, lab testing, and paediatric clinical care tools. |
| 7 | bioMérieux | biomerieux.com | Infectious Diseases Product Manager / Lab Solutions Director | Excellent fit for microbiology, diagnostics, and hospital laboratory decision-makers. |
| 8 | Thermo Fisher Scientific | thermofisher.com | Regional Sales Manager / Laboratory Solutions Specialist / Product Marketing Manager | Strong buyer fit for research tools, lab workflows, molecular diagnostics, and clinical science. |
| 9 | Qiagen | qiagen.com | Molecular Diagnostics Manager / Clinical Applications Specialist | Strong relevance in molecular testing, infectious disease research, and lab adoption. |
| 10 | Bayer | bayer.com | Medical Affairs Lead / Global Product Manager / Evidence Generation Manager | Relevant for women’s and child health, infectious disease support, and healthcare partnerships. |
| 11 | Johnson & Johnson | jnj.com | Medical Affairs Director / Healthcare Partnerships Manager | Broad healthcare portfolio and strong congress engagement capability. |
| 12 | AstraZeneca | astrazeneca.com | Medical Affairs Manager / Scientific Engagement Lead | Useful for respiratory infection, immunology, and broader healthcare stakeholder outreach. |
| 13 | Oxford University Hospitals NHS Foundation Trust | ouh.nhs.uk | Consultant Paediatrician / Infectious Diseases Lead / Clinical Research Manager | Hospital decision-makers and academic clinicians are highly relevant to specialist medical meetings. |
| 14 | Great Ormond Street Hospital | gosh.nhs.uk | Consultant in Paediatric Infectious Diseases / Research Lead | One of the most relevant children’s hospitals for paediatric specialist engagement. |
| 15 | Karolinska Institutet | ki.se | Professor / Principal Investigator / Research Program Director | Strong academic research fit for infectious disease, immunology, and paediatrics. |
| 16 | University College London | ucl.ac.uk | Clinical Lecturer / Research Fellow / Department Head | Top-tier academic and translational research audience for specialist congress lists. |
| 17 | European Centre for Disease Prevention and Control | ecdc.europa.eu | Epidemiologist / Public Health Specialist / Program Manager | High-value public health stakeholder for infectious disease policy and surveillance. |
| 18 | Medtronic | medtronic.com | Hospital Account Manager / Clinical Specialist | Useful if the client serves hospital-based technology or patient monitoring environments. |
5️⃣ Job profiles, industries & event type
Best job profiles to target:
- Consultant in Paediatric Infectious Diseases
- Medical Director
- Head of Infectious Diseases
- Clinical Development Director
- Medical Affairs Director
- Medical Science Liaison
- Laboratory Director
- Microbiology Lead
- Research Professor / Principal Investigator
- Hospital Procurement Manager
- Vaccine Program Manager
- Public Health Epidemiologist
- Clinical Research Manager
- Diagnostics Product Manager
- Paediatric Department Head
Best industry filters to use:
- Hospital & Health Care
- Medical Practice
- Research
- Higher Education
- Biotechnology
- Pharmaceuticals
- Medical Devices
- Public Policy
- Government Administration
- Information Services
- Professional Training & Coaching
- Market Research
- Laboratory and diagnostics-related company keywords
This is a specialist medical congress, so the buyer list should be shaped around clinical authority, scientific influence, hospital purchasing, and research leadership rather than general business titles.
6️⃣ Estimated attendance / expected footfall
Estimated total attendance: approximately 1,500 to 2,500+
The exact number varies by year, location, and scientific program strength. Attendance for this kind of event is typically smaller than a mass commercial expo, but the quality of contacts is significantly higher. Most attendees are specialists with direct or indirect influence over treatment protocols, diagnostics, clinical adoption, and research collaboration.
For attendee-list value, this means the event is ideal when your client wants a highly qualified healthcare database rather than broad volume.
7️⃣ Key focus areas & buyer engagement
Key focus areas include:
- Paediatric infectious disease prevention and treatment
- Vaccine science and immunization strategy
- Antimicrobial resistance and stewardship
- Respiratory and viral infections
- Microbiology, virology, and laboratory diagnostics
- Hospital infection control and clinical guidelines
- Emerging infectious diseases
- Public health surveillance and epidemiology
- Clinical trials and pediatric drug development
- Academic research and translational medicine
Best buyer engagement approach:
The best outreach angle is based on scientific relevance and practical support for clinical practice. Instead of a generic “attendee list” pitch, the stronger message is that this event contains high-value healthcare professionals, research leaders, hospital decision-makers, and medical product influencers working in paediatric infectious disease and related disciplines.
This makes the event especially valuable for:
- Diagnostic and laboratory companies
- Vaccine manufacturers
- Medical software and data solution providers
- Healthcare education and training providers
- Clinical research and trial support organizations
- Hospital equipment and infection control suppliers
- Medical publishers and congress sponsors
8️⃣ Client-product fit note
Please share your client website before finalizing the best buyer list. For an event like this, the strongest target companies and job titles change based on the product your client sells.
Examples:
- If the client sells diagnostics, lab tools, or molecular testing, the best buyers are lab directors, microbiology leaders, diagnostics product managers, and hospital pathology departments.
- If the client sells vaccines or pharma services, the best buyers are medical affairs teams, clinical development leaders, and vaccine program stakeholders.
- If the client sells healthcare software or data solutions, target hospital administrators, clinical research managers, infection control teams, and public health analysts.
- If the client sells education, publishing, or CME solutions, target professors, fellows, department heads, and conference education planners.
If you share the client website, I can narrow this to the best buyer companies, titles, and industries with much higher accuracy.
9️⃣ Final recommendation
This is a very strong event for specialist healthcare attendee-list research, especially for clients in diagnostics, vaccines, pharmaceuticals, hospital solutions, laboratory science, research services, and medical education.
It is not a broad-volume event, but it is a high-intent, high-quality buyer environment. The attendee base is credible, influential, and relevant to healthcare purchasing, clinical adoption, and scientific partnership.
Quality rating for attendee-list sales: 9/10
Best-fit segments to collect:
- Paediatric infectious disease clinicians
- Hospital specialists and consultants
- Laboratory and diagnostics leaders
- Pharma and vaccine medical affairs teams
- Academic researchers and professors
- Public health and epidemiology professionals
- Scientific exhibitors and sponsors
If you want, send the client website next and I will refine this into a buyer-focused list with the best matching companies, titles, and industry filters for this specific event.
Data sheet
44th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID 2026) – Event Attendee & Buyer Profile Analysis
Event date: 1 June 2026 – 5 June 2026
Location: Bologna, Emilia-Romagna, Italy
Event status: Upcoming
Research date: 22 June 2026
Event Overview
| Event Name | 44th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID 2026) |
| Event Date | 1 June 2026 – 5 June 2026 |
| Event Status | Upcoming |
| Venue | Bologna, Italy. Specific venue name not publicly confirmed in the research basis provided. |
| City | Bologna |
| State / Region | Emilia-Romagna |
| Country | Italy |
| Organizer | European Society for Paediatric Infectious Diseases (ESPID) |
| Official Event Website | espidmeeting.org / espid.org |
| Event Type | Medical conference; scientific annual meeting; paediatric infectious diseases; clinical research; diagnostics; vaccines; public health; laboratory science |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Education & Training |
| Audience Reach | International specialist medical and research audience, with strong European concentration |
| Estimated Attendance / Expected Footfall | Estimated 1,500 to 2,500+ attendees based on historical specialist congress scale and event profile. Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Estimated |
| Main Purpose of Event | To convene clinicians, researchers, hospital specialists, diagnostics stakeholders, vaccine experts, public health professionals, and academic leaders focused on paediatric infectious diseases, treatment pathways, surveillance, prevention, and translational research. |
About the Event
The ESPID Annual Meeting is a specialist scientific and clinical conference serving the paediatric infectious diseases community. It typically brings together paediatric infectious disease physicians, hospital clinicians, microbiologists, virologists, epidemiologists, vaccine researchers, diagnostic experts, pharmacists, public health professionals, and academic investigators focused on infections affecting infants, children, and adolescents.
From a commercial and partnership standpoint, this event matters because it concentrates a high-value expert audience rather than broad consumer traffic. It is especially relevant for organizations selling diagnostics, vaccines, laboratory technologies, clinical decision support, medical devices, hospital software, surveillance tools, research services, and education partnerships. For lead generation, the event is more useful for quality outreach and account targeting than for mass-volume attendee acquisition.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Paediatric infectious disease physicians | Children’s hospitals, university hospitals, specialist clinics | Clinical evaluators, product champions, treatment pathway influencers | High relevance for diagnostics, vaccines, medical software, clinical education, and therapeutic partnerships |
| Hospital microbiology and virology leaders | Hospital labs, academic medical centers, reference laboratories | Technical decision-makers and specification influencers | Strong fit for lab instrumentation, molecular diagnostics, sequencing, sample management, and quality systems |
| Clinical researchers and principal investigators | Universities, research institutes, teaching hospitals, clinical trial units | Protocol influencers, trial collaborators, grant and research platform evaluators | Strong fit for CRO services, data platforms, biomarkers, assay development, and study support |
| Vaccine and pharmaceutical medical affairs teams | Vaccine manufacturers, pharma companies, biotech firms | Partnership, evidence-generation, and KOL engagement roles | High value for alliance building, sponsored research, education, and market access support |
| Public health and epidemiology professionals | National public health institutes, ministries, disease surveillance bodies, international agencies | Policy, surveillance, and program implementation influence | Relevant for surveillance platforms, immunization support, health informatics, and population health analytics |
| Hospital pharmacy and antimicrobial stewardship teams | Hospital networks, paediatric centers, academic hospitals | Formulary, utilization, and implementation input | Relevant for therapeutics, stewardship software, formulary intelligence, and clinical workflow tools |
| Hospital procurement and supply chain stakeholders | Hospital systems, laboratories, public health buyers | Commercial approval, tendering, and vendor onboarding roles | Relevant for capital equipment, diagnostics contracts, consumables, software, and managed services |
| Academic program and society leaders | Medical societies, universities, training institutions | Education, collaboration, and guideline influence | Useful for sponsorships, training tools, CME support, and thought-leadership partnerships |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Bologna | Host-city clinicians, university faculty, hospital specialists, local organizers, Italian med-tech and pharma representatives | Medium | Local participation likely led by university hospital and regional health stakeholders |
| Emilia-Romagna | Regional hospitals, public health bodies, teaching institutions, laboratory networks | Medium | Strong hospital and academic relevance, especially for paediatric and infectious disease practice |
| Italy | National clinicians, paediatricians, microbiologists, infectious disease researchers, health system stakeholders | High | Home-country attendance typically strengthened by reduced travel friction and national society networks |
| Europe | Core audience from EU and wider European hospitals, universities, children’s hospitals, public health and vaccine networks | Very High | Primary source of delegates due to ESPID’s European society base and clinical specialty focus |
| North America | Selected academic speakers, collaborating researchers, diagnostics and vaccine industry teams | Medium | Likely represented through research collaboration and industry participation |
| Global ex-Europe | WHO-linked experts, global children’s health researchers, multinational pharma and diagnostic companies | Medium | International reach is meaningful but still specialist rather than mass-market |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The meeting serves an international scientific community and attracts cross-border participation from hospital, academic, public health, and industry stakeholders. |
| Regional / European | Secondary concentration | Most delegates are likely to come from Europe due to society affiliation, specialty focus, and practical travel access. |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| European Society for Paediatric Infectious Diseases (ESPID) | Association / scientific society | Host organization with direct access to specialist members, faculty, and scientific leadership | espid.org | Executive Director, Meeting Manager, Partnerships Lead, Scientific Committee Member | Confirmed Current-Year Participant |
| Azienda USL di Bologna | Regional healthcare organization | Relevant local healthcare ecosystem stakeholder in the host city | ausl.bologna.it | Clinical Director, Procurement Manager, Infectious Diseases Lead, Laboratory Director | Strong Market Fit, Attendance Not Confirmed |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | University hospital | Host-city academic hospital with likely relevance to paediatric and infectious disease specialists | aosp.bo.it | Head of Paediatrics, Infectious Disease Consultant, Lab Director, Purchasing Officer | Strong Market Fit, Attendance Not Confirmed |
| Bambino Gesù Children’s Hospital | Children’s hospital | Major paediatric referral center relevant to infectious disease care, diagnostics, and research | ospedalebambinogesu.it | Head of Infectious Diseases, Director of Laboratory Medicine, Clinical Research Manager | Strong Market Fit, Attendance Not Confirmed |
| Meyer Children’s Hospital | Children’s hospital | Important Italian paediatric hospital likely relevant to ESPID topic areas | meyer.it | Paediatric ID Specialist, Procurement Manager, Research Director | Strong Market Fit, Attendance Not Confirmed |
| Great Ormond Street Hospital | Children’s hospital | Leading European paediatric center with infectious disease, immunology, and research relevance | gosh.nhs.uk | Consultant in Paediatric Infectious Diseases, R&D Lead, Procurement Category Manager | Strong Market Fit, Attendance Not Confirmed |
| Erasmus MC | Academic medical center | Strong paediatric and infectious disease research profile aligned with ESPID themes | erasmusmc.nl | Professor, Clinical Research Lead, Department Head, Lab Manager | Strong Market Fit, Attendance Not Confirmed |
| Karolinska University Hospital | University hospital | High-value Nordic academic and hospital buyer environment for infectious disease solutions | karolinska.se | Clinical Director, Paediatric Specialist, Innovation Manager, Diagnostics Lead | Strong Market Fit, Attendance Not Confirmed |
| Charité – Universitätsmedizin Berlin | University hospital | Major European research and clinical institution for infectious disease science | charite.de | Department Chair, Trial PI, Procurement Officer, Lab Director | Strong Market Fit, Attendance Not Confirmed |
| Institut Pasteur | Research institute | Highly relevant infectious disease research organization for collaboration and scientific technology outreach | pasteur.fr | Research Group Leader, Lab Head, Program Director | Strong Market Fit, Attendance Not Confirmed |
| European Centre for Disease Prevention and Control (ECDC) | Public health agency | Relevant for surveillance, epidemiology, vaccination policy, and public health collaboration | ecdc.europa.eu | Programme Manager, Surveillance Expert, Scientific Officer | Strong Market Fit, Attendance Not Confirmed |
| World Health Organization (WHO) | International public health organization | Relevant for immunization, infectious disease surveillance, and child health guidance | who.int | Technical Officer, Program Lead, Scientific Advisor | Strong Market Fit, Attendance Not Confirmed |
Note: The table above includes a mix of confirmed organizer participation and strong market-fit prospecting targets relevant to ESPID 2026. Current-year public attendee and buyer lists were not publicly confirmed in the research basis available.
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Head of Paediatric Infectious Diseases | Clinical | Director / Department Head | High influence over adoption, evaluation, and referral pathways |
| 2 | Consultant / Attending Physician, Paediatric Infectious Diseases | Clinical | Manager / Specialist | Daily end-user and strong clinical influencer for diagnostics and therapies |
| 3 | Laboratory Director | Laboratory / Diagnostics | Director | Key decision-maker for equipment, assays, workflow, and reference lab partnerships |
| 4 | Professor / Principal Investigator | Research | Senior / Executive | Ideal for research partnerships, trials, publications, and evidence generation |
| 5 | Director of Clinical Research | Research / Innovation | Director | Relevant for study support, platforms, registries, and external collaborations |
| 6 | Procurement Manager | Procurement / Supply Chain | Manager | Commercial entry point for vendor qualification and tender processes |
| 7 | Category Manager, Diagnostics / Laboratory | Procurement | Manager | Important for sourcing diagnostic platforms and consumables |
| 8 | Medical Affairs Director | Medical Affairs | Director | Key industry role for scientific engagement, advisory boards, and partnership strategy |
| 9 | Public Health Program Manager | Public Health / Epidemiology | Manager / Director | Relevant for surveillance systems, vaccination strategy, and implementation tools |
| 10 | Hospital Pharmacist / Antimicrobial Stewardship Lead | Pharmacy / Clinical Governance | Manager / Specialist | Relevant for therapy use, stewardship, and workflow integration |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core clinical and provider audience | Children’s hospitals, university hospitals, specialist paediatric centers |
| 2 | Research | High density of scientific investigators and research labs | Research institutes, translational science platforms, disease surveillance projects |
| 3 | Higher Education | University medical schools and academic centers are strongly represented | Faculty outreach, trial collaboration, education and training products |
| 4 | Pharmaceuticals | Relevant for anti-infectives, pediatric therapies, and scientific engagement | Medical affairs, partnerships, sponsored studies, evidence generation |
| 5 | Biotechnology | Relevant for vaccines, diagnostics, pathogen science, and translational innovation | Pipeline partnerships, biomarker tools, infectious disease platforms |
| 6 | Medical Devices | Diagnostics hardware and clinical devices align well with event needs | Point-of-care systems, testing platforms, monitoring tools |
| 7 | Government Administration | Public health institutes and health agencies are relevant participants | Surveillance, immunization, disease control, health program implementation |
| 8 | Information Technology & Services | Relevant for clinical informatics, data tools, interoperability, and research platforms | Clinical software, registry systems, research data capture, decision support |
| 9 | Computer Software | Many suppliers target diagnostics software, analytics, and workflow tools | AI-assisted diagnostics, stewardship software, analytics dashboards |
| 10 | Health, Wellness & Fitness | Selective fit for preventive health, patient education, and child health support tools | Patient engagement and prevention-related solutions |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | 1,500 to 2,500+ | Estimated | Specialist international medical congress scale; historical society meeting profile | Attendance figure not publicly confirmed by the organizer. |
| Exhibitor count | Not publicly confirmed | Unconfirmed | No verified current-year public exhibitor list in the research basis available | May be available later via sponsor or exhibition prospectus |
| Buyer count | Not publicly confirmed | Unconfirmed | Scientific medical conferences typically do not publish discrete buyer counts | Commercial value is concentrated among hospital, research, and public health decision-makers |
| Speaker count | Not publicly confirmed | Unconfirmed | Agenda details not fully verified in the supplied research basis | Likely substantial due to scientific program format |
| Sponsor count | Not publicly confirmed | Unconfirmed | Pending official sponsor or industry partner publication | May include pharma, vaccine, diagnostic, and laboratory suppliers |
| Historical attendance | Specialist society conference with strong international medical audience | Historical / prior-year evidence | Long-running annual meeting format; 44th edition indicates mature recurring event | Prior-year participation evidence. Not a confirmed attendee list for the current edition. |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Paediatric infectious disease management | Better diagnosis, treatment guidance, and care pathways | Clinical education, product evidence, KOL-led evaluation | Therapeutics, diagnostic support, clinical software |
| Vaccines and immunization | Prevention strategy, efficacy evidence, implementation support | Medical affairs dialogue, public health partnership discussions | Vaccines, cold-chain tools, education resources, immunization analytics |
| Diagnostics and laboratory science | Faster pathogen detection, workflow efficiency, test accuracy | Demo-led outreach, validation studies, lab workflow reviews | PCR platforms, point-of-care diagnostics, sequencing, lab informatics |
| Antimicrobial stewardship | Appropriate therapy use and resistance management | Clinical governance discussions and pharmacy alignment | Stewardship software, utilization analytics, therapy support tools |
| Clinical research and trials | Collaboration partners, study infrastructure, data capture | Research networking, investigator meetings, protocol support | CRO services, EDC platforms, biosample management, trial analytics |
| Public health and surveillance | Monitoring outbreaks, pediatric disease burden, vaccination impact | Agency and hospital collaboration, policy-oriented discussions | Surveillance systems, dashboards, epidemiology tools, reporting software |
| Medical education and guideline dissemination | Training, CME, specialist updates, best-practice adoption | Sponsored symposia, content partnerships, educational platforms | Digital learning, education sponsorships, evidence libraries |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | The audience is highly specialized and aligned with infectious disease clinical, research, and diagnostics purchasing influence. |
| Decision-maker availability | High | Clinical heads, lab directors, PIs, and medical affairs leaders are more likely than generalist events, though not all are direct budget owners. |
| Data collection potential | Medium | Scientific congresses often restrict attendee list access and may not publish full buyer directories. |
| Apollo targeting potential | High | Hospital, research, biotech, pharma, and public health filters can map closely to the expected audience profile. |
| Geographic targeting potential | High | European targeting is especially strong, with useful extension to Italy, UK, Germany, France, Benelux, Nordics, and selected global research hubs. |
| Best outreach approach | High | Use science-led outreach, clinical value proof, pilot proposals, publication support, and KOL or evidence-based messaging. |
| Overall lead quality | High | The event is highly suitable for focused B2B lead generation in healthcare, diagnostics, research, and scientific partnerships. |
| Best use case | High-value account targeting | Best for ABM, strategic introductions, partnership mapping, and specialist list building rather than generic high-volume lead scraping. |
| Limitations / risks | Medium | Current-year attendee confirmation may be limited; some delegates are scientific influencers rather than direct procurement signatories. |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Research; Higher Education; Pharmaceuticals; Biotechnology; Medical Devices; Government Administration; Information Technology & Services; Computer Software | Capture core healthcare, academic, public health, and industry buyer segments |
| Departments | Clinical, Research, Medical Affairs, Procurement, Operations, Laboratory, Innovation, Public Health | Focus on evaluators, adopters, and buyers |
| Seniority | Director, Head, VP, CXO, Partner, Owner, Manager, Senior | Reach decision-makers and high-influence specialists |
| Job titles | Head of Paediatric Infectious Diseases; Consultant Paediatric Infectious Diseases; Laboratory Director; Director of Clinical Research; Principal Investigator; Medical Affairs Director; Procurement Manager; Category Manager Diagnostics; Hospital Pharmacist; Public Health Program Manager | Target both clinical and commercial influence points |
| Geography | Italy, United Kingdom, Germany, France, Spain, Netherlands, Belgium, Switzerland, Sweden, Denmark, Norway, Austria, Ireland, broader Europe | Match the likely European delegate base |
| Employee size | 201-500; 501-1,000; 1,001-5,000; 5,001-10,000; 10,001+ | Prioritize hospitals, academic institutions, large research centers, and established industry accounts |
| Keywords | paediatric infectious diseases, pediatric infectious diseases, microbiology, virology, vaccines, immunization, antimicrobial stewardship, molecular diagnostics, clinical microbiology, epidemiology, surveillance, child health, translational research | Narrow results to the event’s true subject-matter audience |
| Technologies, if relevant | LIMS, EHR integration, diagnostic informatics, PCR, sequencing, surveillance software | Useful for diagnostic, software, and lab-tech prospecting |
| Revenue range, if relevant | Mid-market to enterprise; public institutions where revenue filter may be less useful | Helps prioritize scalable hospital systems and established life sciences companies |
| Company type | Hospitals, university medical centers, research institutes, government agencies, vaccine manufacturers, biotech firms, diagnostic companies | Aligns with highest-likelihood participants and adjacent buying organizations |
Suggested Apollo Search Logic: ("paediatric infectious diseases" OR "pediatric infectious diseases" OR microbiology OR virology OR vaccine OR immunization OR "molecular diagnostics" OR epidemiology OR surveillance) AND (hospital OR university OR research OR public health OR laboratory) AND title contains (head OR director OR professor OR consultant OR manager OR officer).
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| ESPID Meeting Website | Official event website | Event branding, meeting identity, annual meeting context, official event ownership | High |
| European Society for Paediatric Infectious Diseases (ESPID) | Official organizer / society website | Organizer identity, society mission, specialty focus, annual meeting continuity | High |
| User-supplied event details | Provided event information | City, region, country, start date, end date, and Bologna location reference | Medium |
| World Health Organization | Relevant institutional source | Public health ecosystem relevance and plausible stakeholder category for event outreach mapping | High for organization relevance; not attendance confirmation |
| European Centre for Disease Prevention and Control | Relevant institutional source | European surveillance and public health buyer relevance | High for organization relevance; not attendance confirmation |
| Official hospital and institution websites listed in sample buyer table | Primary organizational websites | Organization identity and strategic fit as buyer-side prospecting targets | High for organization verification; not event attendance confirmation |
| Research note | Verification limitation | Specific venue name, exhibitor count, sponsor count, speaker count, and attendee count were not publicly confirmed in the verified basis available for this datasheet. | Important limitation |
Suitability for B2B attendee list building: Yes, but best used for specialist account mapping and high-value buyer profiling rather than expecting a broad public attendee file. Scientific medical meetings often require cautious verification and role-based targeting.
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 44th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID 2026) — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds